Coronavirus (COVID-19) Infection in

Pregnancy
Information for healthcare professionals
Version 7: Published Thursday 9 April 2020

1
Contents

Summary of updates 3-4

1. Introduction 5-9

2.  Advice for health professionals to share with pregnant women 10-13

3.  Advice for all midwifery and obstetric services caring for 14-20
pregnant women

4.  Advice for services caring for women with suspected or 21-36

confirmed COVID-19

5. Advice for services caring for women following recovery from 37-39
confirmed COVID-19

Acknowledgements 40

Appendix 41-48

References 49-53

2
Summary of updates
Previous updates have been summarised in Appendix 2. New updates for this version of the guideline are
summarised here.

Version Date Summary of changes

7 9.4.20 1.4: Update to data from ICNARC and inclusion of a report of 43 pregnant women
with COVID-19 from New York.

7 9.4.20 1.4: New comment on risk of venous thromboembolism from COVID-19.

7 9.4.20 2.3: Advice for pregnant women added – if they are advised to attend a face-to-
face antenatal appointment, this is because the appointment is important and the
benefit of attending is perceived to be greater than the possible risk of infection
with COVID-19 caused by leaving home. Added also emphasised advice to contact
maternity services if concerns during pregnancy.
7 9.4.20 3.1: New section of reducing the risk to women of new infection caused by attending
maternity settings. All other subsections in section 3 have been re-numbered.

7 9.4.20 3.2: New comment on visitor restrictions in maternity settings.

7 9.4.20 3.2: List of risk factors which contribute to mental ill health in pregnant women, and
acknowledgement of the risk of increasing domestic violence with policy for social
distancing, moved to section 3.6 on maternal mental wellbeing.

7 9.4.20 3.3: Advice about induction of labour changed to reference update to Saving Babies’
Lives Care Bundle.

3
7 9.4.20 4.2 Section 4.2 renamed ‘Women with unconfirmed COVID-19 but symptoms
suggestive of possible infection’ to allow for inclusion of new recommendations on
women who call the maternity unit with possible COVID-19 infection (not just attend
in person).

7 9.4.20 4.2: Additional recommendations made to consider usual differential diagnoses

in women who call the maternity unit to report a new fever/cough/respiratory
symptoms.

7 9.4.20 4.3.1: New subsection added on the care of pregnant women who are self-isolating at
home with suspected COVID-19.

7 9.4.20 4.4: Changed to subsection 4.3.3 (subsequent subsections re-numbered).

7 9.4.20 4.6.1: New recommendations re. prophylactic low molecular weight heparin to reduce
risk of venous thromboembolism with COVID-19 infection in pregnancy, and to
consider pulmonary embolism if women with COVID-19 suddenly deteriorate.

7 9.4.20 4.7.2: Statement on calling neonatal team early to inform them of imminent birth of a
baby to a woman with COVID-19 moved to section 4.5, because it applies to all cases
of COVID-19, not just in women with severe disease.

4
1. Introduction

5
1. Introduction
The following advice is provided as a resource for UK healthcare professionals based on a combination of
available evidence, good practice and expert advice. The priorities are:

(i) The reduction of transmission of COVID-19 to pregnant women.

(ii) The provision of safe care to pregnant women with suspected/confirmed COVID-19.

Please be aware that this is very much an evolving situation and this guidance is a living document that is being
updated as new information becomes available. We therefore suggest that you visit this page regularly for
current advice.

On 20th March 2020, the UK Obstetric Surveillance System (UKOSS) launched a registry for all women
admitted to UK hospitals with confirmed COVID-19 infection in pregnancy. Further information can be found
here.

This guidance will be kept under regular review as new evidence emerges. If you would like to suggest
additional areas for this guidance to cover, any clarifications required or to submit new evidence for
consideration, please email COVID-19@rcog.org.uk. Please note, we will not be able to give individual clinical
advice or information for specific organisational requirements via this email address.

1.1 The virus

Novel coronavirus (SARS-COV-2) is a new strain of coronavirus causing COVID-19, first identified in Wuhan
City, China. Other human coronavirus (HCoV) infections include HCoV 229E, NL63, OC43 and HKU1, which
usually cause mild to moderate upper-respiratory tract illnesses like the common cold, Middle East Respiratory
Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).

1.2 Epidemiology
The virus appears to have originated in Hubei province in China towards the end of 2019. Within Europe, Italy
and Spain are the countries currently most affected. The World Health Organization (WHO) publishes a daily
international situation report with an additional Situation Dashboard illustrating information by individual
countries. The total number of confirmed cases in the UK is published by the Department of Health and
Social Care, and is available in a visual dashboard.

6
This situation however is changing rapidly. For the most up-to-date advice please consult local health protection
agencies. Health protection in the United Kingdom is a devolved matter and links to local guidance are available
for England, Wales, Scotland and Northern Ireland. Public Health England (PHE) and Public Health Scotland
(PHS) have been cited throughout this document; specific guidance from the other areas of the UK will be
updated as they become available. At the time of writing, Public Health Wales are aligning with PHE on case
definitions, assessment, infection prevention and control and testing. We will update the RCOG guidance if this
changes.

1.3 Transmission
Most cases of COVID-19 globally have evidence of human to human transmission. This virus can be readily
isolated from respiratory secretions, faeces and fomites. There are two routes by which COVID-19 can be
spread. The first is directly through close contact with an infected person (within 2 metres) where respiratory
secretions can enter the eyes, mouth, nose or airways. This risk increases the longer someone has close contact
with an infected person who has symptoms. The second route is indirectly via the touching of a surface, object
or the hand of an infected person contaminated with respiratory secretions and subsequently touching one’s
own mouth, nose or eyes. Healthcare providers are recommended to employ strict infection prevention and
control (IPC) measures; as per local Health Protection guidance.

Pregnant women do not appear more likely to contract the infection than the general population. Pregnancy
itself alters the body’s immune system and response to viral infections in general, which can occasionally cause
more severe symptoms. This will be the same for COVID-19.

With regard to vertical transmission (transmission from woman to her baby antenatally or intrapartum),
emerging evidence now suggests that vertical transmission is probable, although the proportion of pregnancies
affected and the significance to the neonate has yet to be determined. Two reports have published evidence
of IgM for SARS-COV-2 in neonatal serum at birth.1,2 Since IgM does not cross the placenta, this is likely to
represent a neonatal immune response to in utero infection. Previous case reports from China suggested that
there was no evidence for this and amniotic fluid, cord blood, neonatal throat swabs, placenta swabs, genital
fluid and breastmilk samples from COVID-19 infected mothers have so far all tested negative for the virus.3-6

The evidence above is all based on small numbers of cases. The situation may change and we will continue
to monitor outcomes. MBRRACE-UK have recently commenced centralised, real-time monitoring of affected
women and their babies through UKOSS, the data from which will be included in future versions of this
guideline.

7
1.4 Effect on pregnant women
There is evolving evidence within the general population that there could be a cohort of asymptomatic
individuals or those with very minor symptoms that are carrying the virus, although the incidence is unknown.
Most women will experience only mild or moderate cold/flu like symptoms. Cough, fever, shortness of breath,
headache and anosmia are other relevant symptoms.

It has long been known that, whilst pregnant women are not necessarily more susceptible to viral illness,
changes to their immune system in pregnancy can be associated with more severe symptoms. This is particularly
true towards the end of pregnancy. More severe symptoms such as pneumonia and marked hypoxia are widely
described with COVID-19 in older people, the immunosuppressed and those with long-term conditions such
as diabetes, cancer and chronic lung disease.7 These same severe symptoms could occur in pregnant women
and so should be identified and treated promptly. The absolute risks are, however, small.8

There have been case reports of women with severe COVID-19 at the time of birth who have required
ventilation and extracorporeal membrane oxygenation.9 A case series from New York of 43 women who
tested positive for COVID-19 showed a similar pattern of disease severity to non-pregnant adults: 86% mild,
9% severe and 5% critical, although the sample size was too small to draw a definitive conclusion and the
comparison not made to age, sex or comorbidity-matched individuals.10 At the time of publication, the most
recent report of Intensive Care National Audit and Research Centre in the UK reported, of the first 2,249
patients admitted to critical care settings with a diagnosis of COVID-19, two were pregnant and ten recently
pregnant (within the last 6 weeks).11 Other reported cases of COVID-19 pneumonia in pregnancy are milder
and with good recovery.12 At the time of publication, cases of maternal death have not yet been reported in
published literature.

Individual responses to viral infection are different for different pregnant women and for different viruses.
However, influenza and pregnancy provides a useful comparator: data from Australia, examining critical illness
in pregnancy and the postpartum period due to the infection H1N1, identified significant increases in critical
illness in later pregnancy, compared with early pregnancy.13 In other types of coronavirus infection (SARS,
MERS), the risks to pregnant women appear to increase in particular during the last trimester of pregnancy. In at
least one study, there was an increased risk of preterm birth being indicated for maternal medical reasons after
28 weeks’ gestation.14

Given that pregnancy is known to be a hypercoagulable state, and emerging evidence suggests that individuals
admitted to hospital with COVID-19 are also hypercoagulable,15 it follows that infection with COVID-19 is

8
likely to be associated with an increased risk of maternal venous thromboembolism (VTE).16 Reduced mobility
resulting from self-isolation at home, or hospital admission, is likely to increase the risk further.

1.5 Effect on the fetus

There are currently no data suggesting an increased risk of miscarriage or early pregnancy loss in relation to
COVID-19. Case reports from early pregnancy studies with SARS and MERS do not demonstrate a convincing
relationship between infection and increased risk of miscarriage or second trimester loss.17

There is no evidence currently that the virus is teratogenic. Very recent evidence has, however, suggested that it
is probable that the virus can be vertically transmitted, although the proportion of pregnancies affected and the
significance to the neonate has yet to be determined.1,2

There are case reports of preterm birth in women with COVID-19, but it is unclear whether this was
iatrogenic in every case, or whether some were spontaneous. Iatrogenic birth was predominantly for maternal
indications related to the viral infection, although there was evidence of fetal compromise and prelabour
preterm rupture of the membranes in at least one report.3, 18

9
2. Advice for health
professionals
to share with
pregnant women

10
2. Advice for health professionals to share with
pregnant women

2.1 General advice

As a pregnant woman the news that you were placed in a ‘vulnerable group’ by the UK Government on
Monday 16 March 2020 may have caused you concern.

The evidence to date is that pregnant women are still no more likely to contract the infection than the general
population. What is known is that pregnancy, in a small proportion of women, can alter the body’s response to
severe viral infections. This is something that midwives and obstetricians have known for many years and are
used to dealing with.

What has driven the decisions made by officials is the need to restrict spread of illness. This is because if the
number of infections were to rise sharply, the number of severely infected pregnant women could also rise,
potentially putting them in danger.

Our general advice is that:

• If you are infected with COVID-19 you are still most likely to have no symptoms or a mild illness from
which you will make a full recovery.

• If you develop more severe symptoms or your recovery is delayed, this may be a sign that you are
developing a more significant chest infection that requires enhanced care. Our advice remains that
if you feel your symptoms are worsening or if you are not getting better, you are recommended to
contact the NHS on 111 (or a local alternative), or your maternity unit, straight away for further
information and advice.

2.2 Advice regarding social distancing and self-isolation

The UK Government has decided that, given the limited information currently available about how COVID-19
could affect pregnancy, it would be prudent for pregnant women to stringently engage with social distancing
measures to reduce the risk of infection.

11
All pregnant women, regardless of gestation, should observe the social distancing guidance available on the
Government website. Advice includes the avoidance of contact with people who are known to have COVID-19
or those who exhibit possible symptoms:

• For all vulnerable people including pregnant women19

• For individuals and households of individuals with symptoms of new continuous cough or fever 20

Women above 28 weeks’ gestation are recommended to be particularly attentive to social distancing and
minimising contact with others.

Major new measures have been announced for people at highest risk from coronavirus. This includes pregnant
women with significant heart disease (congenital or acquired) or any individuals with specific cancers, severe
respiratory conditions (such as cystic fibrosis and severe asthma) and those with rare diseases and inborn
errors of metabolism that significantly increase the risk of infections (such as sickle cell disease).21

Specific recommendations regarding going to work have been published separately on the RCOG website.

2.3 Advice regarding your appointments or urgent visits to clinics and hospitals
If you are well at the moment and have had no complications in your previous pregnancies, the following
practical advice may be helpful:

o If you have a routine scan or visit due in the coming days, please contact your maternity unit for
advice and to agree a plan. You may still be advised to attend for a visit, but this appointment may
change due to staffing requirements.

o If you are between appointments, please wait to hear from your maternity team.

o If you are advised to attend for a scan or an appointment by your local maternity team, this is
because the need for the appointment is greater than your risk of being exposed to COVID-19.
Antenatal care is essential to support you in having a healthy pregnancy and so we strongly advise
you do attend if asked to do so. If you have any concerns about this, please discuss with your
maternity unit.

If you are attending more regularly in pregnancy, then your maternity team will be in touch with plans for
further appointments, as required.

12
Whatever your personal situation please consider the following:

o M
 aternity care is essential and has been developed over many years to reduce complications in
pregnant women and babies. The risks of not attending antenatal care include harm to you, your
baby or both of you, even in the context of coronavirus. It is important that you keep in contact
with your maternity team and continue to attend your scheduled routine care when you are well.

o If you are concerned about your or your baby’s wellbeing, including the baby’s movements, it
remains of critical importance that you seek advice and care from maternity services without delay.
This is a very challenging time, particularly if you have concerns about your pregnancy and are
worried about entering a hospital. Maternity units are doing everything they can to minimise the
spread of coronavirus infection to healthy women and their babies, including restricting access to
visitors, using appropriate protection equipment and infection control measures. It is very important
not to be deterred from coming into hospital when you or your baby need care. If you have an
urgent problem related to your pregnancy but not related to coronavirus, get in touch using the
same emergency contact details you already have.

o If you or anyone in your household has symptoms of COVID-19, please contact your maternity
team and they will arrange the right place and time to come for your visits. You should not attend a
routine clinic.

o   ou will be asked to come alone to clinical appointments, or keep the number of people with you
Y
to one (including midwifery visits in your home). This will include being asked not to bring your
children with you to appointments. This is important in order to protect maternity staff, other
women and babies, and you and your family from the risk of infection.

o   here may be a need to reduce the number of antenatal visits you have. This will be communicated
T
with you, and will be done as safely as possible, taking into account available evidence on the safe
number of visits required. Please attend all your scheduled appointments, and if you have concerns
about this please discuss with your maternity team.

At this time, it is particularly important that you help your maternity team take care of you. If you have had an
appointment cancelled or delayed and are not sure of your next contact with your maternity team, please let
them know by using the contact numbers provided to you at booking.

13
 3. Advice for all
midwifery and
obstetric services
caring for pregnant
women

14
3. Advice for all midwifery and obstetric services
caring for pregnant women
3.1 Reducing the transmission of COVID-19 in maternity settings
Most women attending maternity services are healthy and are advised to maintain stringent social distancing.
It is recognised that attending maternity services, particularly where located in hospitals, may cause significant
anxiety about the possibility of contracting COVID-19. It is important that maternity services do all they can to
protect women from contracting COVID-19 during their maternity care by following PHE infection prevention
and control guidance stringently and using appropriate PPE.

Particular consideration should be given to the care of pregnant women with comorbidities who are ‘shielded’.
These women should be provided with a mask during hospital visits. Their status should be clearly noted at any
handover; shared waiting areas should be avoided; and if admitted they should be in a side room.

3.2 General advice regarding the continued provision of antenatal and

postnatal services
The situation is currently moving very fast and reconfiguration of services is likely to be necessary. At present,
the following is recommended:

• Antenatal and postnatal care is based on years of evidence to keep women and babies safe in
pregnancy and birth. Antenatal and postnatal care should therefore be regarded as essential care
and women should be encouraged to attend, despite being advised to otherwise engage with social
distancing measures.

• Women should be advised to attend routine antenatal care unless they meet current self-isolation
guidance for individuals and households of individuals with symptoms of new continuous cough
or fever.20 Maternity care has been shown repeatedly to be essential, and studies in the UK and
internationally have shown that if women do not attend antenatal services they are at increased risk of
maternal death, stillbirth, and other adverse perinatal outcomes. 22,23

• Units should rapidly seek to adopt teleconferencing and videoconferencing capability and consider
what appointments can be conducted remotely. We hope to issue further guidance on this soon.

15
 The NHS has provided guidance on the relaxation of information governance requirements for video
calling.

• Record keeping remains paramount.

• Electronic record systems should be used and, where remote access for staff or women is an available
function, this should be expedited. When seeing women face-to- face, simultaneous electronic
documentation will facilitate future remote consultation.

• Units should appoint a group of clinicians to coordinate care for women forced to miss appointments
due to self-isolation. Women should be able to notify the unit of their self-isolation through telephone
numbers that are already available to them. Appointments should then be reviewed for urgency and
either converted to remote appointments, attendance appropriately advised or deferred.

o  F or women who have had symptoms, appointments can be deferred until 7 days after the start
of symptoms, unless symptoms (aside from persistent cough) persevere.

o  F or women who are self-isolating because someone in their household has possible symptoms
of COVID-19, appointments should be deferred for 14 days.

• Units should have a system to flag women who have missed serial appointments, which is a particular
risk for women with small children who may become sequentially unwell. Any woman who has
a routine appointment delayed for more than 3 weeks should be contacted and an appointment
scheduled urgently.

• Pregnant women will continue to need at least as much support, advice, care and guidance in relation
to pregnancy, childbirth and early parenthood as before the pandemic. It is important that care is
available to ensure continued support for women with multiple complex needs. Women living with
adversity including poverty, homelessness, substance misuse, being an asylum seeker, experiencing
domestic abuse and mental health problems will continue to require timely expert support.

• Individualised plans for women requiring frequent review may be necessary.

• Visitor restrictions, including for women admitted to maternity services for antenatal and postnatal care,
are in place in most settings across the UK. Midwifery, obstetric and support staff should be aware,
as they normally are, of the support needs for all women and the practical challenges of caring for
newborns after birth.

16
3.3 General advice regarding possible service modifications during COVID-19
Service modifications may be required to assist women practising social distancing measures, to reduce the risk
of transmission between women, staff and other clinic/hospital visitors and to provide care to women who are
self-isolating for suspected/confirmed COVID-19.

Units should identify areas where there are clear possibilities for rationalisation of services.

Particular possibilities include reducing induction of labour for indications that are not strictly necessary.25,26
Consideration should also be given to routine growth scans where this is not for a strict guidance-based
indication. Additional guidance is available for services in England in the Saving Babies’ Lives Care Bundle,
appendix G, available here. It may be possible to improve outpatient provision of induction of labour,
depending on availability of transport to hospital.

We are developing, together with a wide range of co-authors, a series of guidance documents to assist
maternity units with changes to services that they provide, which may occur during the COVID-19 pandemic.
These are available on the RCOG website and include:

• Guidance for early pregnancy services.

• Guidance for antenatal and postnatal services.

• Guidance for antenatal screening (including screening ultrasound).

• Guidance for fetal medicine services.

• Guidance for maternal medicine clinics.

• Guidance for self-monitoring of blood pressure in pregnancy (for women with hypertensive disorders
of pregnancy).

3.4 General advice regarding intrapartum services

• Intrapartum services should be provided in a way that is safe, with reference to minimum staffing


requirements and the ability to provide emergency obstetric, anaesthetic and neonatal care where
needed.

17
• Women should be permitted and encouraged to have a birth partner present with them during their
labour and birth. A single, asymptomatic birth partner should be permitted to stay with the woman,
at a minimum, through labour and birth, unless the birth occurs under general anaesthetic. Having a
trusted birth partner present throughout labour is known to make a significant difference to the safety
and well-being of women in childbirth.27-29

o   W
 hen a woman contacts the maternity unit in early labour, she should be asked about whether
she or her birth partner have had any symptoms which could suggest COVID-19 in the preceding
7 days. If her partner has had symptoms in the last 7 days or less, she should be advised that her
partner should not attend the unit with her and she should be advised to bring another birth
partner who is symptom free, explaining the need to protect maternity staff and other women and
families from the risk of infection.

o   O
 n attendance to the maternity unit, all birth partners should be asked whether they have had
any symptoms which could suggest COVID-19 in the preceding seven days. If the onset of these
symptoms was seven days or less ago, or they still have symptoms (other than persistent cough),
they should be asked to leave the maternity unit immediately and self-isolate at home.

o  T
 he symptoms to ask about are: fever, acute persistent cough, hoarseness, nasal discharge/
congestion, shortness of breath, sore throat, wheezing or sneezing.30

o B
 irth partners who are not symptomatic of COVID-19 may be asked to remain by the woman’s
bedside, not walk around the ward/hospital and should be given clear advance guidance on what is
expected of them if they accompany the woman to the operating theatre (e.g. for caesarean birth).
This is particularly important given the known challenges of staff communication when wearing full
PPE.

• R
 estrictions on other visitors, such as limiting the number of birth partners to one, restricting any or
all visitors to antenatal or postnatal wards (to ensure compliance with social distancing measures), and
preventing swapping of postnatal visitors, should follow hospital policy. We support visitor restrictions
across all hospital wards, including maternity units, to comply with government recommendations
for social distancing and reduce the risk of transmission to women, their babies, staff and visitors
themselves.

• The evidence for the safety of birth settings that are not co-located with an obstetric unit is based on
the availability of ambulance services to enable rapid transfer, and appropriate staffing levels.31If these
are not in place, it may be reasonable to rationalise the provision of these services.

18
3.5 Smoking cessation and carbon monoxide monitoring in pregnancy
Smoking is very likely to be associated with more severe disease in COVID-19, although presently available
research cannot accurately estimate the effect. It is therefore particularly important to emphasise the need to
stop smoking as soon as possible to all women.32

The National Centre for Smoking Cessation and Training (NCSCT) has recommended the pausing of
monitoring carbon monoxide during pregnancy, as a precautionary measuring following concern about the risk
of coronavirus transmission. Other aspects of care targeted to identify smokers and assist with cessation should
still continue. In particular, all women should be asked about their smoking status at antenatal appointments,
and referred to stop smoking services (which will likely be telephone based) on an opt out basis. Nicotine
replacement therapy should be recommended and household members who smoke signposted to support.
Further guidance is available. In England, further detail is available in Appendix H of the Saving Babies’ Lives
Care Bundle.

3.6 Maternal mental wellbeing

This pandemic will inevitably result in an increased amount of anxiety in the general population, and this is likely
to be even more so for pregnant women as it represents an additional period of uncertainty. Specifically, these
anxieties are likely to revolve around:

• COVID-19 itself,

• The impact of social isolation resulting in reduced support from wider family and friends,

• The potential of reduced household finances,major changes in antenatal and other NHS care with
appointments being changed from face-to-face to telephone contact.

Isolation, bereavement, financial difficulties, insecurity and inability to access support systems are all widely
recognised risk factors for mental ill-health. The coronavirus epidemic also increases the risk of domestic
violence.24 Additional advice regarding support for victims of domestic violence during the COVID-19
pandemic is available here.

The change in appointment style will also make assessment for women experiencing domestic violence, women
with safeguarding concerns, women who are misusing substances and women with complex mental health
difficulties more challenging. If identified, the usual referrals to appropriate services should still be made.

19
A general increase in anxiety is to be expected in the current situation. Often simply acknowledging these
difficulties can help to contain some of these anxieties. It is critically important that support for women and
families is strengthened as far as possible; that women are asked about mental health at every contact; and
that women are urged to access support through remote means, where possible. This includes accessing
sources of self-help for anxiety and stress, and when necessary self-referral to local IAPT (Improving Access to
Psychological Therapies) services in England or equivalents in other nations.

In Scotland, advice is available from Parentclub and NHS Inform.

Further information is available from the RCPsych website.

20
 4. Advice for
services caring
for women
with suspected
or confirmed
COVID-19

21
4. Advice for services caring for women with
suspected or confirmed COVID-19
The following advice refers mostly to the care of women in the second or third trimesters of pregnancy.

Care of women in the first trimester should include attention to the same infection prevention and
investigation/diagnostic guidance as for the general population with COVID-19. Separate RCOG guidance is
available for modifications to early pregnancy services during the pandemic.

Specific advice regarding the acute care of pregnant women admitted with moderate or severe symptoms of
COVID-19 can be found in section 4.6.1.

4.1 General advice for services providing care to pregnant women with
suspected or confirmed COVID-19, where hospital attendance is necessary
The following suggestions apply to all hospital/clinic attendances for women with suspected or confirmed
COVID-19:

• Women should be advised to attend via private transport where possible or call 111/999 for advice as
appropriate.

• If an ambulance is required, the woman should alert the call handler that she is currently in self-isolation
for possible or confirmed COVID-19.

• Women should be asked to alert a member of maternity staff to their attendance when on the
hospital premises, by telephone, prior to entering the hospital.

• Staff providing care should take personal protective equipment (PPE) precautions as per local health
protection guidance.33

• Women should be met at the maternity unit entrance by staff wearing appropriate PPE and be
provided with a surgical face mask (not a filtering face piece level 3 (FFP3) mask). The face mask should
not be removed until the woman is isolated in a suitable room.

22
• Women should immediately be escorted to an isolation room or cohort bay/ward, suitable for the
majority of care during their hospital visit or stay.

o Isolation rooms or ward bays should ideally have a defined area for staff to put on and remove
PPE, and suitable bathroom facilities.

o Further advice on care in isolation rooms versus COVID-19 cohort bays is available from PHE.

• Only essential staff should enter the room and visitors should be kept to a minimum.

• All non-essential items from the clinic/scan room should be removed prior to the woman’s arrival.

• All clinical areas used must be cleaned after use, as per health protection guidance.33

4.2 Women with unconfirmed COVID-19 but symptoms suggestive of possible

infection
Women may attend maternity units in person, or call maternity services by telephone, to report symptoms
which are suggestive of COVID-19.

When women phone maternity services for advice regarding symptoms which may be attributed to
COVID-19, the healthcare professionals are also advised to consider differential diagnoses which could
otherwise explain fever, cough, shortness of breath or similar. This includes, but is not limited to: urinary tract
infection, chorioamnionitis, pulmonary embolism etc.

For women who attend maternity units in person:

Maternity departments with direct entry for women and the public should have a system in place for identifying
potential cases as soon as possible, to prevent potential transmission to other patients and staff. This should be
at first point of contact, before anyone takes a seat in the maternity waiting area (either near the entrance or at
reception), to ensure early recognition and infection control.

Women should be tested for COVID-19 if they meet PHE criteria. Current criteria (correct at the time of
publishing this update) are:

23
Women who are being/are admitted to hospital with one of the following:

• Clinical/radiological evidence of pneumonia,

• Acute Respiratory Distress Syndrome (ARDS),

• Fever ≥37.8 AND at least one of acute persistent cough, hoarseness, nasal discharge/congestion,
shortness of breath, sore throat, wheezing or sneezing.

Furthermore, we recommend that women with an isolated fever should be investigated and treated according
to the unit protocol. This will include sending a full blood count. If lymphopenia is identified on the full blood
count, testing for COVID-19 should be arranged.

Until test results are available, the woman should be treated as though she has confirmed COVID-19. The full
Public Health England guidance has been summarised in a flowchart for this guideline (Appendix 1).30

Women may attend hospital for reasons directly related to pregnancy and also have coincidental symptoms
meeting the COVID-19 case definition. In cases of uncertainty, seek additional advice or in case of emergency,
investigate and treat as suspected COVID-19 until advice can be sought. Suspected COVID-19 should not
delay administration of therapy that would be usually given (for example, IV antibiotics in woman with fever and
prolonged rupture of membranes).

In the event of a pregnant woman attending with an obstetric emergency and being suspected or confirmed
to have COVID-19, maternity staff must first follow IPC guidance. This includes transferring the woman to an
isolation room and donning appropriate PPE. This can be time consuming and stressful for women, their birth
partner and health professionals. Once IPC measures are in place, the obstetric emergency should be dealt
with as the priority. Do not delay obstetric management in order to test for COVID-19.

Further care, in all cases, should continue as for a woman with confirmed COVID-19, until a negative test result
is obtained.

4.3 Antenatal care in women with suspected or confirmed COVID-19, who are
self-isolating at home
4.3.1 Care of the pregnant woman

Women with mild-moderate symptoms of suspected COVID-19 are advised to self-isolate at home, according
to government guidelines.

24
For women who are self-isolating at home, ensure they stay well hydrated and are mobile throughout this
period. Women who have thromboprophylaxis already prescribed should continue taking this.

If women are concerned about the development of VTE during a period of self-isolation, a clinical review
(in person or remotely) should be attempted to assess VTE risk, and thromboprophylaxis considered and
prescribed on a case-by-case basis. If their VTE risk score at booking is 3 or more then commencement of
prophylactic low molecular weight heparin (LMWH) should be recommended. A prescription can be sent
through the post along with a video link of how to self-inject, or a video appointment following receipt.

Local procedures should be followed in ensuring the supply of LMWH.

4.3.2 Managing planned appointments during the self-isolation period

Routine appointments for women with suspected or confirmed COVID-19 (growth scans, oral glucose
tolerance test, antenatal community or secondary care appointments) should be delayed until after the
recommended period of self-isolation. Advice to attend more urgent pre-arranged appointments (fetal
medicine surveillance, high risk maternal secondary care) will require a senior decision on urgency and potential
risks/benefits.

Trusts/boards are advised to arrange local, robust communication pathways for senior maternity staff members
to screen and coordinate appointments missed due to suspected or confirmed COVID-19.

If it is deemed that obstetric or midwifery care cannot be delayed until after the recommended period of
isolation, infection prevention and control measures should be arranged locally to facilitate care. Pregnant
women in self-isolation who need to attend should be contacted by a local care coordinator to re-book urgent
appointments / scans, preferably at the end of the working day.

If ultrasound equipment is used, this should be decontaminated after use in line with guidance.

4.3.3 Attendance for unscheduled/urgent antenatal care in women with suspected or confirmed COVID-19

When possible, early pregnancy units (EPUs) or maternity triage units should provide advice over the
telephone. If this requires discussion with a senior member of staff who is not immediately available, a return
call should be arranged as soon as possible.

Local protocols are required to ensure women with confirmed or suspected COVID-19 are isolated on arrival

25
to EPUs or maternity triage units and full PPE measures are in place for staff (see Section 4.1).

Please see RCOG advice for modifications to early pregnancy and antenatal services.

Medical, midwifery or obstetric care should otherwise be provided as per routine.

4.4 Women who develop new symptoms of COVID-19 during admission

(antenatal, intrapartum or postnatal)
There is an estimated incubation period for COVID-19 of 0-14 days (mean 5-6 days); an infected woman may
therefore initially present asymptomatically, developing symptoms later during an admission.34

Health professionals should be aware of this possibility, particularly those who regularly measure patient vital
signs (e.g. healthcare assistants). In the event of new onset of respiratory symptoms with/without unexplained
fever , which meet the PHE case-definition for suspected COVID-19 (section 4.2), the woman should be
isolated and appropriate infection control precautions initiated in line with UK Infection Prevention and
Control Guidance. The local Infection Prevention and Control team should also be notified.

Furthermore, we recommend that women with an isolated fever should be investigated and treated according
to the unit’s protocol. This will include sending a full blood count. If lymphopenia is identified on the full
blood count, or the woman has other symptoms suggestive of COVID-19, testing for COVID-19 should be
considered.

It is recognised that this may lead to substantial numbers of women treated as suspected COVID-19.
Suspected COVID-19 should not delay administration of therapy that would be usually given (for example, IV
antibiotics in woman with fever and prolonged rupture of membranes).

Recommended care for women who have moderate to severe symptoms of COVID-19 during pregnancy is
covered in section 4.6.1.

4.5 Women attending for intrapartum care with suspected or confirmed

COVID-19
4.5.1 Attendance in labour

All women should be encouraged to call the maternity unit for advice in early labour. Women with mild
COVID-19 symptoms can be encouraged to remain at home (self-isolating) in early (latent phase) labour as
per standard practice.

26
If homebirth or birth in a midwifery-led unit is planned, a discussion should be initiated with the woman
regarding the potentially increased risk of fetal compromise in active phase of labour if infected with
COVID-19.3 Attending an obstetric unit, where the baby can be monitored using continuous electronic fetal
monitoring (EFM), should be recommended for birth.

When a woman decides to attend the maternity unit, general recommendations about hospital attendance
apply (see section 4.1).

Once settled in an isolation room, a full maternal and fetal assessment should be conducted to include:

• Assessment of the severity of COVID-19 symptoms by the most senior available clinician and
discussion with a multidisciplinary team (MDT), including an infectious diseases or general medical
specialist.

• Maternal observations including temperature, respiratory rate and oxygen saturations.

• Confirmation of the onset of labour, as per standard care.

• EFM using cardiotocograph (CTG).

o In two Chinese case series, including a total of 18 pregnant women infected with COVID-19 and
19 babies (one set of twins), there were eight reported cases of fetal compromise.3,6 Given this
relatively high rate of fetal compromise, continuous EFM in labour is currently recommended for all
women with COVID-19.

• If the woman attends with a fever, investigate and treat as per RCOG guidance on sepsis in pregnancy,
but also consider active COVID-19 as a cause of sepsis and investigate according to PHE guidance
(see section 4.2 for COVID-19 case definition).

If there are no concerns regarding the condition of either the woman or baby, women who would usually be
advised to return home until labour is more established, can still be advised to do so, if appropriate transport is
available.

Women should be given the usual advice regarding signs and symptoms to look out for, but in addition should
be told about symptoms that might suggest deterioration related to COVID-19 following consultation with the
medical team (e.g. difficulty in breathing).

27
If labour is confirmed, then care in labour should ideally continue in the same isolation room.

4.5.2 Care in labour

The following considerations apply to women in spontaneous or induced labour:

• When a woman with confirmed or suspected COVID-19 is admitted to the maternity suite, the
following members of the MDT should be informed: consultant obstetrician, consultant anaesthetist,
midwife-in-charge, consultant neonatologist, neonatal nurse in charge and infection control team.

• Efforts should be made to minimise the number of staff members entering the room and units should
develop a local policy specifying essential personnel for emergency scenarios.

• There is evidence of household clustering and household co-infection.35 Asymptomatic birth partners
should be asked to wash their hands frequently. If symptomatic, birth partners should remain in self-
isolation and not attend the unit. Women should be advised to identify an alternative birth partner,
should the need arise.

• Maternal observations and assessment should be continued as per standard practice, with the addition
of hourly oxygen saturations.

o Aim to keep oxygen saturation more than 94%, titrating oxygen therapy accordingly.

• If the woman develops a fever, investigate and treat as per RCOG guidance on sepsis in pregnancy, but
also consider active COVID-19 as a cause of sepsis and investigate according to PHE guidance (see
section 4.2 for COVID-19 case definition).

• Given the rate of fetal compromise reported in the two Chinese case series,3,6 the current
recommendation is for continuous electronic fetal monitoring in labour.

•  here is currently no evidence to favour one mode of birth over another and therefore mode of
T
birth should be discussed with the woman, taking into consideration her preferences and any obstetric
indications for intervention. Mode of birth should not be influenced by the presence of COVID-19,
unless the woman’s respiratory condition demands urgent intervention for birth.

o  t present, where vaginal secretions have been tested for COVID-19, the results have been
A
negative.

28
• The use of birthing pools in hospital should be avoided in suspected or confirmed cases, given the risk
of infection via faeces.

• There is no evidence that epidural or spinal analgesia or anaesthesia is contraindicated in the presence
of coronaviruses. Epidural analgesia should therefore be recommended in labour, to women with
suspected or confirmed COVID-19 to minimise the need for general anaesthesia if urgent intervention
for birth is needed.

• There is no evidence that the use of Entonox is an aerosol-generating procedure (AGP).

• Entonox should be used with a single-patient microbiological filter. This is standard issue throughout
maternity units in the UK.

• In case of deterioration in the woman’s symptoms, refer to Section 4.6 for additional considerations,
and make an individual assessment regarding the risks and benefits of continuing the labour versus
proceeding to emergency caesarean birth if this is likely to assist efforts to resuscitate the woman.

• When caesarean birth or other operative procedure is advised, follow guidance from Section 4.8.2.

o F or emergency caesarean births, donning PPE is time-consuming. This may impact on the decision
to delivery interval but it must be done. Women and their families should be told about this
possible delay.

• An individualised informed discussion and decision should be made regarding shortening the length of
the second stage of labour with elective instrumental birth in a symptomatic woman who is becoming
exhausted or hypoxic.

• The neonatal team should be given sufficient notice at the time of birth, to allow them to attend and
don PPE before entering the room/theatre.

• Given a lack of evidence to the contrary, delayed cord clamping is still recommended following birth,
provided there are no other contraindications. The baby can be cleaned and dried as normal, while the
cord is still intact.

• Following birth, women should be risk assessed for VTE and the first dose of LMWH administered as
soon as possible after delivery provided there is no postpartum haemorrhage and regional analgesia

29
 has not been used. Where regional analgesia has been used, LMWH can be administered 4 hours after
the last spinal injection or removal of the epidural catheter.15

4.5.3 Specific advice regarding Personal Protective Equipment for Labour

General advice from PHE on type and specification of PPE is available here. Particular advice from Public
Health England on type and specification of PPE for different maternity settings is available as part of the table
here.

Caesarean birth: specific advice on PPE when caring for pregnant women with suspected/confirmed
COVID-19 requiring caesarean birth is detailed in section 4.8.

4.5.4 Elective (planned) caesarean birth

Where women with suspected or confirmed COVID-19 have scheduled appointments for pre-operative care
and elective caesarean birth, an individual assessment should be made to determine whether it is safe to delay
the appointment to minimise the risk of infectious transmission to other women, healthcare workers and,
postnatally, to her baby.

In cases where elective caesarean birth cannot safely be delayed, the general advice for services providing care
to women admitted when affected by suspected/confirmed COVID-19 should be followed (see Section 4.1), as
should the advice on PPE for caesarean birth (see section 4.8).

Obstetric management of elective caesarean birth should be according to usual practice.

4.5.5 Planned induction of labour

As for elective caesarean birth, an individual assessment should be made regarding the urgency of planned
induction of labour for women with mild symptoms and suspected or confirmed COVID-19. If induction of
labour cannot safely be delayed, the general advice for services providing care to women admitted to hospital
when affected by suspected/confirmed COVID-19 should be followed (see Section 4.1). Women should be
admitted into an isolation room; in which they should ideally be cared for the entirety of their hospital stay.

30
4.6 Additional considerations for women with confirmed COVID-19 and
moderate/severe symptoms
The following recommendations apply in addition to those specified for women with no or mild symptoms.

4.6.1 Women admitted antenatally/postnatally

When pregnant women are admitted to hospital with deterioration in symptoms and suspected or confirmed
COVID-19 infection, the following recommendations apply:

• A MDT discussion planning meeting ideally involving a consultant physician (infectious disease specialist
where available), consultant obstetrician, midwife-in-charge and consultant anaesthetist responsible for
obstetric care should be arranged as soon as possible following admission. The discussion should be
shared with the woman. The following should be included:

o Key priorities for medical care of the woman and her baby, and her birth preferences.

o M
 ost appropriate location of care (e.g. intensive care unit, isolation room in infectious disease ward
or other suitable isolation room) and lead specialty.

o C
 oncerns among the team regarding special considerations in pregnancy, particularly the condition
of the baby.

• The priority for medical care should be to stabilise the woman’s condition with standard supportive
care therapies.

o  useful summary on supportive care for adults diagnosed with COVID-19 has been published by
A
the WHO.36

o S pecific guidance on the management of patients with COVID-19 who are admitted to critical
care has now been published by NICE.37

• Particular considerations for pregnant women are:

o Hourly observations including respiratory rate, looking for the number and trends.

- Young fit women can compensate for a deterioration in respiratory function and are able to

31
 maintain normal oxygen saturations before they then suddenly decompensate.

- Signs of decompensation include an increase in oxygen requirements or FiO2 > 40%, a

respiratory rate of greater than 30, reduction in urine output, or drowsiness, even if the
saturations are normal. Escalate urgently if any of these signs develop in a woman who is
pregnant or has recently given birth.

o Titrate oxygen to keep saturations >94%.

o R
 adiographic investigations should be performed as for the non-pregnant adult; this includes chest
X-ray and computerised tomography (CT) of the chest. Chest imaging, especially CT chest, is
essential for the evaluation of the unwell patient with COVID-19 and should be performed when
indicated, and not delayed because of fetal concerns.38-40 Abdominal shielding can be used to
protect the fetus as per normal protocols.

o C
 onsider additional investigations to rule out differential diagnoses e.g. ECG, CTPA as appropriate,
echocardiogram. Do not assume all pyrexia is due to COVID-19 and also perform full sepsis-six
screening.

o C
 onsider bacterial infection if the white blood cell count is raised (lymphocytes usually normal or
low with COVID-19) and commence antibiotics.

o  pply caution with IV fluid management. Try boluses in volumes of 250-500mls and then assess for
A
fluid overload before proceeding with further fluid resuscitation.36

o  ll pregnant women admitted with COVID-19 infection (or suspected COVID-19 infection)
A
should receive prophylactic LMWH, unless birth is expected within 12 hours (e.g. for a woman
with increasing oxygen requirements).15

- Where women with complications of COVID-19 are under the care of other teams, such as
intensivists or acute physicians, the appropriate dosing regimen of LMWH should be discussed
in an MDT that includes a senior obstetrician and a local VTE expert.

o  he diagnosis of PE should be considered in women with chest pain, worsening hypoxia

T
(particularly if there is a sudden increase in oxygen requirements) or in women whose
breathlessness persists or worsens after expected recovery from COVID-19.

o The frequency and suitability of fetal heart rate monitoring should be considered on an individual

32
 basis, taking into consideration the gestational age of the fetus and the maternal condition. If urgent
intervention for birth is indicated for fetal reasons, birth should be expedited as normal, as long as
the maternal condition is stable.

o If maternal stabilisation is required before intervention for birth, this is the priority, as it is in other
maternity emergencies, e.g. severe pre-eclampsia.

o  n individualised assessment of the woman should be made by the MDT to decide whether
A
emergency caesarean birth or induction of labour is indicated, either to assist efforts in maternal
resuscitation or where there are serious concerns regarding the fetal condition. Individual
assessment should consider: the maternal condition, the fetal condition, the potential for
improvement following elective birth and the gestation of the pregnancy. The priority must always
be the wellbeing of the woman.

o  here is no evidence to suggest that steroids for fetal lung maturation, when they would usually
T
be offered, cause any harm in the context of COVID-19. Steroids should therefore be given when
indicated in NICE guidance. As per standard practice, urgent intervention for birth should not be
delayed for their administration.41

There are some reports that even after a period of improvement there can be a rapid deterioration. Following
improvement in a woman’s condition, consider an ongoing period of observation, where possible, for a further
24-48 hours. On discharge, advise the woman to return immediately if she becomes more unwell.

4.6.2 Women requiring intrapartum care

In addition to recommendations in Sections 4.8 and 4.9.1, for women with moderate or severe COVID-19
requiring intrapartum care it is also recommended that:

• With regard to mode of birth, an individualised decision should be made. There are currently no
overt obstetric contraindications to any method for mode of birth except water birth (see above).
Caesarean birth should be performed if indicated based on maternal and fetal condition as in normal
practice.

• Given the association of COVID-19 with acute respiratory distress syndrome,42 women with moderate
to severe symptoms of COVID-19 should be monitored using hourly fluid input/output charts. Efforts
should be targeted towards achieving neutral fluid balance in labour, in order to avoid the risk of fluid
overload.

33
4.7 Postnatal care
4.7.1 Neonatal care

There are limited data to guide the postnatal care of babies of women who tested positive for COVID-19 in
the third trimester of pregnancy. Literature from China has advised separate isolation of the infected woman
and her baby for 14 days. However, routine precautionary separation of a woman and a healthy baby should
not be undertaken lightly, given the potential detrimental effects on feeding and bonding. Given the current
limited evidence, we advise that women and healthy babies, not otherwise requiring neonatal care, are kept
together in the immediate postpartum period.

A risk and benefits discussion with neonatologists and families to individualise care in babies that may be more
susceptible is recommended. We emphasise that this guidance may change as knowledge evolves.

All babies born to COVID-19 positive mothers should be cared for as per RCPCH guidance.43

4.7.2 Infant feeding

It is reassuring that in six Chinese cases, breastmilk tested negative for COVID-19;3 however, given the small
number of cases, this evidence should be interpreted with caution. The main risk of breastfeeding is the close
contact between the baby and the woman, who is likely to share infective droplets. In the light of the current
evidence, we advise that the benefits of breastfeeding outweigh any potential risks of transmission of the virus
through breastmilk. The risks and benefits of feeding choices, including the risk of holding the baby in close
proximity where women may be infected, should be discussed with the parents.

The following precautions should be taken to limit viral spread to the baby:

• Wash hands before touching the baby, breast pump or bottles.

• Avoid coughing or sneezing on the baby while feeding.

• Consider wearing a fluid-resistant surgical face mask, if available, while feeding or caring for the baby.

• Where a breast pump is used, follow recommendations for pump cleaning after each use.

• Considering asking someone who is well to feed the baby.

34
For babies who are bottle fed with formula or expressed milk, strict adherence to sterilisation guidelines is
recommended.

Where women are expressing breastmilk in hospital, a dedicated breast pump should be used.

4.7.3 Discharge and readmission to hospital

Any women or babies requiring readmission for postnatal obstetric or neonatal care during the period of self-
isolation due to suspected or confirmed COVID-19 are advised to telephone their local unit ahead of arrival
and follow the attendance protocol as described in Section 4.1. The place of admission will depend on the level
of care required for the woman or baby.

4.8 Specific peri-operative advice for healthcare professionals caring for

pregnant women with suspected/confirmed COVID-19 who require
surgical intervention
4.8.1 General advice for obstetric/emergency gynaecology theatre

• Elective/planned obstetric procedures (e.g. cervical cerclage or caesarean) should be scheduled at the
end of the operating list.

• Non-elective or emergency procedures should be carried out in a second obstetric theatre, where
available, allowing time for a full postoperative theatre clean as per local health protection guidance.33

• The number of staff in the operating theatre should be kept to a minimum, and all must wear
appropriate PPE.

• All staff (including maternity, neonatal and domestic) should have been trained in the use of PPE so that
24-hour emergency theatres are available and possible delays reduced.

• Anaesthetic management for women with symptoms or confirmed COVID-19 should be with
reference to anaesthetic guidance.

• Departments should consider running dry-run simulation exercises to prepare staff, build confidence
and identify areas of concern to prepare for emergency transfers to the operating theatre.

35
4.8.2 Advice regarding Personal Protective Equipment for caesarean birth

Caesarean birth: the level of PPE required by healthcare professionals caring for a woman with COVID-19
who is undergoing a caesarean birth should be determined based on the risk of requiring a general anaesthetic
(GA). Intubation for a GA is an AGP. This significantly increases the risk of transmission of coronavirus to the
attending staff. Regional anaesthesia (spinal, epidural or CSE) is not an AGP.

For the minority of caesarean births, where GA is planned from the outset, all staff in theatre should wear PPE,
with a FFP3 mask. The scrub team should scrub and don PPE before the GA is commenced.

For a non-urgent caesarean birth where regional anaesthesia is planned, the risk of requiring a GA is very small,
as there is no time pressure.

The chance of requiring conversion to a GA during a caesarean birth commenced under regional anaesthesia
is small, but this chance increases with the urgency of caesarean birth. In situations where there are risk factors
that make conversion to a GA more likely, the decision on what type of PPE to wear should be judged based
on the individual circumstances. If the risk of requiring conversion to a GA is considered significant, the theatre
team should wear PPE appropriate to a GA in readiness. An example is a woman whose epidural has been
suboptimal during labour, which is ‘topped-up’ for an emergency caesarean birth.

These recommendations will be updated as required as further evidence and advice

36
 5. Advice for services
caring for women
following isolation for
symptoms, or recovery
from confirmed
COVID-19

37
5. Advice for services caring for women following
isolation for symptoms, or recovery from
confirmed COVID-19
5.1 Antenatal care for pregnant women following self-isolation for symptoms
suggestive of COVID-19
Scheduled antenatal care that falls within the self-isolation period should be rearranged for post-isolation.
No additional tests, including ultrasound assessment of fetal growth, are necessary for women not requiring
hospitalisation for COVID-19.

Even if a woman has previously tested negative for COVID-19, if she re-presents with symptoms that meet the
case definition (section 4.2), COVID-19 should be suspected.

5.2 Antenatal care for pregnant women following hospitalisation for confirmed
COVID-19 illness
All women admitted to hospital with COVID-19 infection should receive at least 10 days of prophylactic
LMWH, following discharge from hospital.

For those recovering after acute illness, further antenatal care should be arranged for after the period of self-
isolation.

Referral to antenatal ultrasound services for fetal growth surveillance is recommended 14 days after resolution
of acute illness. Although there is no evidence yet that fetal growth restriction (FGR) is a risk of COVID-19,
two-thirds of pregnancies with SARS were affected by FGR and a placental abruption occurred in a MERS case,
so ultrasound follow-up seems prudent.44 45

5.3 Postnatal care for pregnant women immediately following hospitalisation

for confirmed COVID-19 illness
All women admitted to hospital with COVID-19 infection should receive at least 10 days of prophylactic
LMWH, following discharge from hospital.

38
For those women who had confirmed or suspected COVID-19 at the time of birth who are then transferred
home for community postnatal care, postnatal care should continue according to the recommended schedule,
where safe to do so.

RCPCH guidance recommends that all families self-isolate at home for 14 days after birth of a neonate to a
mother with active COVID-19 infection.

Families should be provided with guidance about how to identify signs of illness in their newborn or worsening
of the mother’s symptoms, and provided with appropriate contact details if they have concerns or questions
about their baby’s wellbeing.

Usual advice about safe sleeping and a smoke free environment should be emphasised, along with provision of
clear advice about careful hand hygiene and infection control measures when caring for and feeding the baby.

Maternity services should offer a combination of face-to-face and remote postnatal follow-up, according to
the woman and baby’s needs. For example, women with hypertensive diseases of pregnancy may require face-
to-face reviews, particularly if they don’t have access to home blood pressure monitoring. If the baby is of
low birth weight or premature, or where there any concerns about feeding, face-to-face appointments will be
needed in order to weigh and examine the baby fully.

Where is it essential that women receive a face-to-face review in the community, midwives are advised to wear
appropriate PPE and follow social distancing and infection control guidance. In order to reduce the exposure
of midwives to risk of infection, for home visits other members of the household should be asked not to be
present in the room when the midwife is examining the mother and baby.

39
 Authors
Edward Morris, President RCOG

Pat O’Brien, Vice President, Membership, RCOG

Gemma Goodyear, Obstetric Fellow, RCOG

Sophie Relph, Obstetric Fellow, RCOG

Jennifer Jardine, Obstetric Fellow, RCOG

Anita Powell, Senior Director Clinical Quality, RCOG

Emma Gilgunn-Jones, Director of Media and Public Relations, RCOG

Ed Mullins, Clinical Advisor to the CMO

Russell Viner, President, RCPCH

David Evans, Consultant Neonatologist, North Bristol NHS Trust

Mary Ross-Davie, Director for Scotland, RCM

Acknowledgments
We wish to thank the following people and teams for expert input and review: The Royal College of
Midwives; the Royal College of Anaesthetists; the Royal College of Paediatrics and Child Health; the
Obstetric Anaesthetists’ Association; Public Health England; Public Health Scotland; NHS England; Scottish
Government; NHS Improvement Infection, Prevention and Control Team; Dr Benjamin Black, Professor Asma
Khalil, Dr Maggie Blott, Dr Giles Berrisford (on behalf of RCPsych), Dr Christine Ekechi, Dr Jahnavi Daru,
Dr Peter MacCallum, Dr Shohreh Beski, Dr Louise Bowles, Dr Lucy Mackillop, Professor Beverley Hunt and
Professor Cathy Nelson-Piercy.

40
Appendix

41
 Appendix 1: Flow chart to assess COVID-19 risk in
maternity unit attendees
Derived from Royal London flowchart developed by Dr Misha Moore

Does the woman either have known COVID-19, or symptoms of cough,

fever of or above 37.8 degrees

No symptoms Symptoms present

No further action -
• Give the woman surgical (non FFP3) face mask and ask to put on
usual care
• Accompany to designated isolation room or area for initial
assessment
• Use full PPE and infection control measures

Does the women have an emergency obstetric issue, or is she in labour?

Emergency obstetric issue/in labour No emergency obstetric issue and not in labour

• Alert designated local team, midwife co-ordinator, obstetric consultant on call and neonatal team
• MW and Obstetric Dr review within 30 minutes

• 
Advise to take own personal
Does she require admission to hospital? transport home immediately
and self-isolate for seven
No days, or attend the hospital’s
designated containment area
Yes
for next action
• 
Rebook any appointment
after seven days and send by
•  iscuss with local designated COVID-19 team regarding best
D post
place of care
• Test woman for COVID-19
• Treat as though confirmed case until results of swabs available

42
Appendix 2: Summary of updates
Version Date Summary of changes

2 12.3.20 1.2: At the time of writing, Public Health Wales are aligning with Public Health
England on case definitions, assessment, infection prevention and control and testing.
We will update this guidance if this changes.

2 13.3.20 2.2: Updated to reflect PHE and health protection advice as per 13.03.20, in particular
to use online symptom checkers and to treat all individuals with symptoms as possibly
having COVID-19

2 13.3.20 3.2: Sentence on who to test updated to reflect advice to test women with symptoms
suggestive of COVID-19 who require admission

2 13.3.20 3.6.4 and 3.6.5: Updated to suggest considering delay of elective caesarean birth or
induction for women with symptoms suggestive of COVID-19 as well as those with
confirmed COVID-19

2 13.3.20 3.8: Infant feeding modified from recommendation to wear a face mask to try and
avoid coughing or sneezing on the baby, and consider wearing face mask where
available

2 13.3.20 4: New section added for antenatal care for pregnant women following self-isolation
for symptoms suggestive of COVID-19

2 13.3.20 5 (new). New section - Advice for pregnant healthcare professionals

2 13.3.20 Appendix 1: Flow chart amended to reflect modified PHE guidance

43
2 13.3.20 References: 19. NHS Staff Council Statement on Covid-19 2020 [Available
from: https://www.nhsemployers.org/-/media/Employers/Documents/
Pay-and-reward/NHS-Staff-Council---Guidance-for-Covid-19-Feb-20.
pdf?la=en&hash=70C909DA995280B9FAE4BF6AF291F4340890445C] accessed 12
March 2020
3 17.3.20 2: Advice for Health Professionals to share with Pregnant Women updated to reflect
current guidelines

3 17.3.20 3: New section added on Advice for all midwifery and obstetric services

3 17.3.20 4.1: General advice to services providing care to pregnant women updated to reflect
advice from chief medical officer on 16/3/20

3 14.3.20 4.1: Advice on cleaning ultrasound equipment added, and reference added

3 17.3.20 4.5: Linked to new national guidance on the actions required when a COVID-19 case
was not diagnosed on admission

3 17.3.20 4.6.2: Recommendations added: There is evidence of household clustering and

household co-infection. Asymptomatic birth partners should be treated as possibly
infected and asked to wear a mask and wash their hands frequently. If symptomatic,
birth partners should remain in isolation and not attend the unit.

The use of birthing pools in hospital should be avoided in suspected or confirmed

cases, given evidence of transmission in faeces and the inability to use adequate
protection equipment for healthcare staff during water birth.

44
3 17.3.20 4.6.2: Advice about Entonox changed to

There is no evidence that the use of Entonox is an aerosol-prone procedure

Entonox should be used with a single-patient microbiological filter. This is standard

issue throughout maternity units in the UK.

3 17.3.20 4.6.4: Anaesthetic management for women with symptoms or confirmed COVID-19,
which was previously in this guidance, has been removed and external links provided

3 17.3.20 4.7.1: Statement inserted ‘Chest imaging, especially CT chest, is essential for the
evaluation of the unwell patient with COVID-19 and should be performed when
indicated and not delayed due to fetal concerns.’

3 17.3.20 Updated to reflect current public health guidance on self-isolation and social
distancing

3 17.3.20 4.7.1: Advice on neonatal management and testing has been removed. Please refer to
RCPCH guidance

3 17.3.20 6: Advice for healthcare professionals updated in line with Chief Medical Officer
statement on Monday 16 March.

4 21.3.20 6: Section on ‘Occupational health advice for employers and pregnant women during
the COVID-19 pandemic’ added, replacing the previous section 6 on ‘Information for
Healthcare Professionals’. Section includes specific recommendations for healthcare
professionals.

45
4 21.3.20 1.3-1.4: Additional information added on the susceptibility of pregnant women to
COVID-19 infection.

4 21.3.20 2: Additional information on social distancing for pregnant women added, particularly
specifying stringent adherence to recommendations for women >28 weeks gestation.

4 21.3.20 4.7: New section added on specific recommendations for PPE during labour and birth

4 21.3.20 1: Addition of information and links for the UKOSS reporting system

4 21.3.20 All: General proofread and editorial changes

4 21.3.20 6: Page 36 title changed to ‘Occupational health advice for employers and pregnant
women during the COVID-19 pandemic’

4.1 26.3.20 Chapter 6: ‘Occupational health advice for employees and pregnant women during
the COVID-19 pandemic’ has been removed from this general guidance on pregnancy
and COVID-19 infection, and published as a separate document given the distinct
audience for the occupational health advice.
4.1 26.3.20 4.7.3: On Personal Protective Equipment updated in line with NHS England guidance

46
5 28.3.20 1.3: Section updated to include new evidence on possible vertical transmission

5 28.3.20 2.2: Sentence added on the major new measures announced by government for
pregnant women with co-existing significant congenital or acquired heart disease.

5 28.3.20 2.3: Section updated to emphasise the need to attend maternity care

5 28.3.20 3: General advice for antenatal care extended to include considerations for vulnerable
women. Section also added on general advice regarding intrapartum services

5 28.3.20 3.1: Specific advice added regarding the cessation of carbon monoxide monitoring
in pregnancy, following advice from the National Centre for Smoking Cessation and
Training.
5 28.3.20 4: Scotland specific links to Health Protection Scotland removed after confirmation
from the Scottish government that National links from gov.uk should be used.

5 28.3.20 4.3.6: Scotland specific links to Health Protection Scotland removed after confirmation
from the Scottish government that National links from gov.uk should be used.

5 28.3.20 4.7.3 and 4.76: Advice on PPE considerations for caesarean birth and general
advice for obstetric theatres moved to new section ‘Specific peri-operative advice
for pregnant women with suspected/confirmed COVID-19 requiring surgical
intervention’.
5 28.3.20 4.8.1: Reference made to new guidance published by NICE on the management of
patients with COVID-19 in critical care.

5 28.3.20 4.8.1: Additional recommendations made for the management of women admitted
during pregnancy with suspected/confirmed COVID-19.
5 28.3.20 4.9.2: Section edited to make infant feeding recommendations to any caregiver, not
just to the mother.

5 28.3.20 4.10: New section on ‘Specific peri-operative advice for pregnant women with
suspected/confirmed COVID-19 requiring surgical intervention’

47
5 28.3.20 5.1: Correction of an error in the title to clarify that this section refers to the
care of women recovering from suspected (not confirmed) COVID-19 for which
hospitalisation was not required.
6 3.4.20 Throughout: References to the new RCOG guidance on (1) antenatal and postnatal
services (2) antenatal screening (3) fetal medicine services (4) maternal medicine
services and (5) self-monitoring of blood pressure, have been added throughout the
document.
6 3.4.20 1.2: New resources signposted on current UK and international disease incidence.

6 3.4.20 1.4: Sentence reporting that there are ‘no reported maternal deaths from COVID-19’
removed because there was recently a possible maternal death reported in
tabloid media. There is not any robust evidence to amend this statement or report
confidently in the guideline.
6 3.4.20 3.2: Addition of new advice on screening birth partners for recent possible symptoms
of COVID-19 when they attend the maternity unit. In addition, suggestion of
information to give the birth partner about what is expected of them whilst they are
in the hospital, to assist staff in reducing the risk of infection transmission and to assist
with communication when birth partners accompany women into operating theatres.
6 3.4.20 3.4: Moved to section 3.2

6 3.4.20 3.5: New section on maternal mental wellbeing during the pandemic

6 3.4.20 4.1 The previous section 4.2 was repetitive of section 3.1 and so has been removed.
Sections 4.2 onwards have been re-numbered.
6 3.4.20 4.3: Inclusion of the PHE case definition for COVID-19 testing, rather than referring
readers to this through the link.
6 3.4.20 4.9: Updates to advice on PPE for caesarean birth, to ensure that these are consistent
with new PHE advice

48
References

49
1. Dong L, Tian J, He S, et al. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her
Newborn. JAMA 2020 doi: 10.1001/jama.2020.4621

2. Zeng H, Xu C, Fan J, et al. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia. JAMA 2020
doi: 10.1001/jama.2020.4861

3. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of
COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020 doi:
https://doi.org/10.1016/S0140-6736(20)30360-3

4. Chen Y, Peng H, Wang L, et al. Infants Born to Mothers With a New Coronavirus (COVID-19). Frontiers in
Pediatrics 2020;8(104) doi: 10.3389/fped.2020.00104

5. Li N, Han L, Peng M, et al. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia:
a case-control study. . Pre-print doi: 10.1101/2020.03.10.20033605

6. Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia.
Transl Pediatr 2020;9(1):51-60. doi: http://dx.doi.org/10.21037/tp.2020.02.06

7. Guan W-j, Ni Z-y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England
Journal of Medicine 2020 doi: 10.1056/NEJMoa2002032

8. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) In: World Health
Organisation, ed., 2020.

9. Liu Y, Chen H, Tang K, et al. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy.
Journal of Infection 2020;Online doi: https://doi.org/10.1016/j.jinf.2020.02.028

10. Breslin N, Baptiste C, Gyamfi-Bannerman C, et al. COVID-19 infection among asymptomatic and
symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City
hospitals. AJOG MFM, 2020.

11. ICNARC report on COVID-19 in critical care. In: ICNARC, ed., 2020.

12. Liu D, Li L, Wu X, et al. Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease
(COVID-19) Pneumonia: A Preliminary Analysis. American Journal of Roentgenology 2020:1-6. doi: 10.2214/
AJR.20.23072

50
13. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort
study. BMJ 2010;340:c1279. doi: 10.1136/bmj.c1279

14. Mullins E, Evans D, Viner R, et al. Coronavirus in pregnancy and delivery: rapid review. Ultrasound in
Obstetrics and Gynaecology (In press) doi: doi: 10.1002/uog.22014

15. Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Venous Thromboembolism during
Pregnancy and the Puerperium, 2015.

16. Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated
intravascular coagulation of patients infected with COVID-19. 2020 [Available from: https://thrombosisuk.
org/covid-19-thrombosis.php accessed 07 April 2020.

17. Zhang J, Wang Y, Chen L, et al. Clinical analysis of pregnancy in second and third trimesters complicated
severe acute respiratory syndrome. Zhonghua Fu Chan Ke Za Zhi 2003;38:516-20.

18. Di Mascio D, Khalil A, Saccone G, et al. Outcome of Coronavirus spectrum infections (SARS, MERS,
COVID 1 -19) during pregnancy: a systematic review and meta-analysis. American Journal ofObstetrics &
Gynecology MFM 2020 doi: https://doi.org/10.1016/j.ajogmf.2020.100107

19. COVID-19: guidance on social distancing and for vulnerable people 2020 [Available from: https://www.gov.
uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people accessed 17
March 2020.

20. Stay at home: guidance for households with possible coronavirus (COVID-19) infection 2020 [Available
from: https://www.gov.uk/government/publications/covid-19-stay-at-home-guidance/stay-at-home-guidance-
for-households-with-possible-coronavirus-covid-19-infection accessed 17 March 2020.

21. Major new measures to protect people at highest risk from coronavirus 2020 [Available from: https://www.
gov.uk/government/news/major-new-measures-to-protect-people-at-highest-risk-from-coronavirus accessed
26 March 2020.

22. Dowswell T, Carroli G, Duley L, et al. Alternative versus standard packages of antenatal care for low‐risk
pregnancy. Cochrane Database of Systematic Reviews 2015(7) doi: 10.1002/14651858.CD000934.pub3

23. Knight M, Bunch K, Tuffnell D, et al. Saving Lives, Improving Mothers’ Care. Lessons learned to inform
maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2014–
16. In: MBRRACE-UK, ed., 2018.

51
24. Fraser E. Impact of COVID-19 Pandemic on Violence against Women and Girls. In: Development UAftDoI,
ed., 2020.

25. Norman JE, Heazell AEP, Rodriguez A, et al. Awareness of fetal movements and care package to reduce
fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trial. Lancet 2018;392(10158):1629-38. doi:
10.1016/S0140-6736(18)31543-5 [published Online First: 2018/10/03]

26. National Institute for Health and Care Excellence. Inducing Labour, 2008.

27. Bohren M, Hofmeyr G, Sakala C, et al. Continuous support for women during childbirth. . Cochrane
Database of Systematic Reviews 2017(7) doi: 10.1002/14651858.CD003766.pub6

28. Bohren MA, Berger BO, Munthe-Kaas H, et al. Perceptions and experiences of labour companionship: a
qualitative evidence synthesis. Cochrane Database of Systematic Reviews 2019(3) doi: 10.1002/14651858.
CD012449.pub2

29. Shakibazadeh E, Namadian M, Bohren MA, et al. Respectful care during childbirth in health facilities globally:
a qualitative evidence synthesis. Bjog 2018;125(8):932-42. doi: 10.1111/1471-0528.15015 [published Online
First: 2017/11/09]

30. COVID-19: investigation and initial clinical management of possible cases 2020 [Available from: https://www.
gov.uk/government/publications/wuhan-novel-coronavirus-initial-investigation-of-possible-cases/investigation-
and-initial-clinical-management-of-possible-cases-of-wuhan-novel-coronavirus-wn-cov-infection accessed 05
March 2020.

31. Birthplace in England Collaborative G, Brocklehurst P, Hardy P, et al. Perinatal and maternal outcomes by
planned place of birth for healthy women with low risk pregnancies: the Birthplace in England national
prospective cohort study. BMJ 2011;343:d7400. doi: 10.1136/bmj.d7400 [published Online First: 2011/11/26]

32. Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tobacco Induced
Diseases 2020;18(March) doi: 10.18332/tid/119324

33. COVID-19: Infection, prevention and control guidance 2020 [Available from: https://www.gov.uk/
government/publications/wuhan-novel-coronavirus-infection-prevention-and-control/wuhan-novel-
coronavirus-wn-cov-infection-prevention-and-control-guidance accessed 05 January 2020.

52
34. Coronavirus disease 2019 (covid-19) Situation Report – 29. 2020 [Available from: https://www.who.int/
docs/default-source/coronaviruse/situation-reports/20200219-sitrep-30-covid-19.pdf?sfvrsn=6e50645_2
accessed 08 March 2020.

35. Pung R, Chiew CJ, Young BE, et al. Investigation of three clusters of COVID-19 in Singapore: implications for
surveillance and response measures. The Lancet doi: 10.1016/S0140-6736(20)30528-6

36. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is
suspected 2020 [Available from: https://www.who.int/publications-detail/clinical-management-of-severe-
acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected accessed 05 March 2020.

37. COVID-19 rapid guideline: critical care in adults. In: Excellence TNIfHaC, ed., 2020.

38. Li X, Xia L. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. AJR
Am J Roentgenol 2020(4):1-7. doi: 10.2214/AJR.20.22954

39. Zhao W, Zhong Z, Xie X, et al. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus
Disease (COVID-19) Pneumonia: A Multicenter Study. . AJR Am J Roentgenol (3):1-6. doi: 10.2214/
AJR.20.22976.

40. Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019
(COVID-19) in China: a report of 1014 cases. . Radiology 2020 doi: 10.1148/radiol.2020200642.

41. Preterm labour and birth. In: National Institute for Health and Care Excellence, ed, 2019.

42. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan,
China. The Lancet 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5

43. Royal College of Paediatrics and Child Health. COVID-19 - Guidance for Paediatric Services. 2020.

44. Swartz D, Graham A. Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2)
Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses
2020:1-16.

45. Alserehi H, Wali G, Alshukairi A, et al. Impact of Middle East Respiratory Syndrome coronavirus ( MERS -
CoV ) on pregnancy and perinatal outcome. BMC Infect Dis 2016:1-4. doi: http://dx.doi.org/10.1186/s12879-
016-1437-y

53
 DISCLAIMER: The Royal College of Obstetricians and Gynaecologists (RCOG) has produced this
guidance as an aid to good clinical practice and clinical decision-making. This guidance is based on
the best evidence available at the time of writing, and the guidance will be kept under regular review
as new evidence emerges. This guidance is not intended to replace clinical diagnostics, procedures
or treatment plans made by a clinician or other healthcare professional and RCOG accepts no
liability for the use of its guidance in a clinical setting. Please be aware that the evidence base for
COVID-19 and its impact on pregnancy and related healthcare services is developing rapidly and the
latest data or best practice may not yet be incorporated into the current version of this document.
RCOG recommends that any departures from local clinical protocols or guidelines should be fully
documented in the patient’s case notes at the time the relevant decision is taken.

@RCObsGyn @rcobsgyn @RCObsGyn

Royal College of Obstetricians and Gynaecologists, 10-18 Union Street, London, SE1 1SZ
T: +44 (0) 20 7772 6200 E: covid-19@rcog.org.uk W: rcog.org.uk Registered Charity No. 213280

54